Chondroitin Sulfate Market Report 2026

Chondroitin Sulfate Market Overview

• Chondroitin Sulfate market size has reached to $1.48 billion in 2025 • Expected to grow to $1.93 billion in 2030 at a compound annual growth rate (CAGR) of 5.3% • Growth Driver: Growing Incidences Of Osteoarthritis Fueling Demand For Chondroitin Sulfate Market • Market Trend: Innovations In Chondroitin Sulfate-Based Solutions Enhance Joint Health And Mobility • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Chondroitin Sulfate Market?

Chondroitin sulfate is a chemical compound found in human and animal cartilage that is commonly used in the treatment of osteoarthritis in conjunction with other substances such as glucosamine. This condition is characterized by joint cartilage degeneration, which can be avoided by supplementing with chondroitin sulfate, which is a key component of cartilage. The main types of chondroitin sulfate are capsule form, tablet form, and powder form. A capsule refers to a compact, measured-out container that contains medication and dissolves (mixes with fluids) when you consume it. They are procured through various sources including bovine, swine, poultry, shark, and synthetic, and used in pet food and veterinary supplements, pharmaceutical and biotech companies, cosmetics, and personal care.

What Is The Chondroitin Sulfate Market Growth Forecast?

The chondroitin sulfate market size is expected to see strong growth in the next few years. It will grow to $1.93 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to increasing aging population, rising awareness of joint health supplements, expansion of nutraceutical markets, growing demand for clean-label ingredients, increasing investments in synthetic chondroitin production. Major trends in the forecast period include increasing use of chondroitin in joint health supplements, rising demand for animal-derived active ingredients, growing adoption in veterinary nutrition, expansion of cosmetic grade chondroitin, enhanced focus on purity and traceability.

What Is The Driver Of The Chondroitin Sulfate Market?

The growing incidences of osteoarthritis are expected to propel the growth of the chondroitin sulfate market going forward. Osteoarthritis is a widespread type of arthritis that affects millions of people globally. It occurs when the protective cartilage that cushions bone ends gradually deteriorates. Chondroitin sulfate is effective in treating osteoarthritis by providing resistance to compression, maintaining structural integrity, promoting homeostasis, slowing down the degenerative process, and alleviating muscular pain. Hence, the growing incidence of osteoarthritis will increase the demand for chondroitin sulfate market. For instance, in October 2025, according to NHS Inform, a Scotland-based national health information service, each year, more than 500,000 individuals require hospital care due to fragility fractures, which are fractures resulting from osteoporosis. Fragility fractures are those that occur from a fall at standing height or lower. Therefore, growing incidences of osteoarthritis are driving the growth of the chondroitin sulfate industry.

Key Players In The Global Chondroitin Sulfate Market

Major companies operating in the chondroitin sulfate market are Seikagaku Corporation, Synutra Ingredients, TSI Group Ltd., Sioux Pharm, Summit Nutritionals International Inc., ZPD A/S, Sino Siam Bio technique Co. Ltd., Bio-gen Extracts Pvt. Ltd., Hebei Sanxin industry Group Co.Ltd., Fidia Farmaceutici S.p.A., Gnosis S.p.A., Pacific Rainbow International Inc., Bioiberica S.A.U., Ruikangda Biochemical Co. Ltd., Guanglong Biochem Co. Ltd., Nippon Zoki Pharmaceutical Co. Ltd., Huiwen Technology Co. Ltd., Runxin Biotechnology Co. Ltd., WanTuMing Biological, QJBCHINA, Hengjie Bio-Pharmaceuticals, Rochem International Inc., Chongqing Aoli Biopharmaceutical Co. Ltd.

Global Chondroitin Sulfate Market Trends and Insights

Major companies operating in the chondroitin sulfate market are focusing on developing advanced solutions, such as multi-ingredient formulations, to enhance joint support, improve mobility, and promote overall musculoskeletal wellness. Multi-ingredient formulations refer to dietary solutions that combine chondroitin sulfate with complementary compounds, such as collagen type II and hyaluronic acid, to provide synergistic benefits for joint function. For instance, in October 2024, Symrise, a Germany-based developer and producer of ingredients and solutions for the flavor, fragrance, and nutrition industries, launched Chondractiv Plus, featuring a collagen-rich hydrolyzed chicken cartilage powder. This solution contains collagen type II, chondroitin sulfate, hyaluronic acid, and proteins. Experts recommend a daily dosage of 1.5 grams to support joint health. The product is backed by an extensive literature review and sensory consumer insights. It is designed for dietary supplements and functional foods, offering a sustainable 3-in-1 hydrolyzed solution to promote joint mobility. Chondractiv Plus integrates natural ingredients with taste-balancing to enhance the consumer experience while providing science-backed support for active lifestyles.

What Are Latest Mergers And Acquisitions In The Chondroitin Sulfate Market?

In November 2024, Borsch Med Pte Ltd, a Singapore-based healthcare and nutrition company, partnered with Zeria Pharmaceutical Co. Ltd. to make joint health accessible for healthier, active aging. Through this partnership, Borsch Med aims to improve access to chondroitin-based joint health supplements from Zeria Pharmaceutical Co. Ltd. for the elderly, supporting healthy aging in the region. Zeria Pharmaceutical Co. Ltd. is a Japan-based company specializing in chondroitin-based joint health products.

What Defines the Chondroitin Sulfate Market?

The chondroitin sulfate market consists of sales of glucuronic acid and N-acetylga-lactosamine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Chondroitin Sulfate Market Report 2026?

The chondroitin sulfate market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chondroitin sulfate industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.